{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:12:34Z","timestamp":1789711954831,"version":"4.0.1"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1248\/bpb.b18-00026","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T18:22:22Z","timestamp":1522520542000},"page":"637-643","source":"Crossref","is-referenced-by-count":28,"title":["Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice"],"prefix":"10.1248","volume":"41","author":[{"given":"Miku","family":"Kuritani","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"},{"name":"Department of Special Needs Dentistry, Division of Dentistry for Persons with Disabilities, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Karakawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Isawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"},{"name":"Department of Pediatric Dentistry, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Chatani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Negishi-Koga","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Funatsu","sequence":"additional","affiliation":[{"name":"Department of Special Needs Dentistry, Division of Dentistry for Persons with Disabilities, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Takami","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Dentistry, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Seeman E, Delmas PD. Bone quality\u2014the material and structural basis of bone strength and fragility. N. Engl. J. Med.<\/i>, 354<\/b>, 2250\u20132261 (2006).","DOI":"10.1056\/NEJMra053077"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G, Scully S, Elliott R, Grisanti M, Morony S, Hong LT, Asuncion F, Li X, Ominsky MS, Stolina M, Dwyer D, Dougall WC, Hawkins N, Boyle WJ, Simonet WS, Sullivan JK. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J. Bone Miner. Res.<\/i>, 24<\/b>, 182\u2013195 (2009).","DOI":"10.1359\/jbmr.081112"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature<\/i>, 402<\/b> (6763suppl.), 43\u201347 (1999).","DOI":"10.1038\/35005552"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev.<\/i>, 20<\/b>, 345\u2013357 (1999).","DOI":"10.1210\/edrv.20.3.0367"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hanada R, Hanada T, Sigl V, Schramek D, Penninger JM. RANKL\/RANK-beyond bones. J. Mol. Med.<\/i>, 89<\/b>, 647\u2013656 (2011).","DOI":"10.1007\/s00109-011-0749-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bartold PM, Cantley MDHD, Haynes DR. Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000<\/i>, 53<\/b>, 55\u201369 (2010).","DOI":"10.1111\/j.1600-0757.2010.00347.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tanabe N, Maeno M, Suzuki N, Fujisaki K, Tanaka H, Ogiso B, Ito K. IL-1\u03b1 stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2<\/sub> production and decreasing OPG production by osteoblasts. Life Sci.<\/i>, 77<\/b>, 615\u2013626 (2005).","DOI":"10.1016\/j.lfs.2004.10.079"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kressin NR, Boehmer U, Nunn ME, Spiro A 3rd. Increased preventive practices lead to greater tooth retention. J. Dent. Res.<\/i>, 82<\/b>, 223\u2013227 (2003).","DOI":"10.1177\/154405910308200314"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Okamatsu N, Sakai N, Karakawa A, Kouyama N, Sato Y, Inagaki K, Kiuchi Y, Oguchi K, Negishi-Koga T, Takami M. Biological effects of anti-RANKL antibody administration in pregnant mice and their newborns. Biochem. Biophys. Res. Commun.<\/i>, 491<\/b>, 614\u2013621 (2017).","DOI":"10.1016\/j.bbrc.2017.07.154"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, Takayanagi H, Kamijo R. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med.<\/i>, 15<\/b>, 1066\u20131071 (2009).","DOI":"10.1038\/nm.2007"},{"key":"11","unstructured":"11) Furuya Y, Mori K, Ninomiya T, Tomimori Y, Tanaka S, Takahashi N, Udagawa N, Uchida K, Yasuda H. Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-\u03baB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts. J. Biol. Chem.<\/i>, 286<\/b>, 37023\u201337031 (2011)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Abe T, Sato T, Kokabu S, Hori N, Shimamura Y, Sato T, Yoda T. Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide. Cytokine<\/i>, 83<\/b>, 1\u20137 (2016).","DOI":"10.1016\/j.cyto.2016.03.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mochizuki A, Takami M, Kawawa T, Suzumoto R, Sasaki T, Shiba A, Tsukasaki H, Zhao B, Yasuhara R, Suzawa T, Miyamoto Y, Choi Y, Kamijo R. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine\/receptor activator of NF-\u03baB ligand. J. Immunol.<\/i>, 177<\/b>, 4360\u20134368 (2006).","DOI":"10.4049\/jimmunol.177.7.4360"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J. Immunol. Methods<\/i>, 394<\/b>, 49\u201354 (2013).","DOI":"10.1016\/j.jim.2013.05.002"},{"key":"15","unstructured":"15) Paquette DW, Hanlon A, Lessem J, Williams RC. Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis\u202f: secondary analysis of a phase 3 trial. J. Periodontol.<\/i>, 75<\/b>, 531\u2013536 (2004)."},{"key":"16","unstructured":"16) Myokai F, Takashiba S, Lebo R, Amar S. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 96<\/b>, 4518\u20134523 (1999)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo J, Takahashi N, Nagai K. Suppression of osteoprotegerin expression by prostaglandin E2<\/sub> is crucially involved in lipopolysaccharide-induced osteoclast formation. J. Immunol.<\/i>, 172<\/b>, 2504\u20132510 (2004).","DOI":"10.4049\/jimmunol.172.4.2504"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and long-term oral bisphosphonate therapy. N. Engl. J. Med.<\/i>, 360<\/b>, 53\u201362 (2009).","DOI":"10.1056\/NEJMoa0802633"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Aghaloo T L, Cheong S, Bezouglaia O, Kostenuik P, Atti E, Dry SM, Flavia Q, Tetradis S. RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J. Bone Miner. Res.<\/i>, 29<\/b>, 843\u2013854 (2014).","DOI":"10.1002\/jbmr.2097"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/4\/41_b18-00026\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T17:13:07Z","timestamp":1570986787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/4\/41_b18-00026\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00026","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}